Abbott Laboratories (ABT)
$106.86
0.00 (0.00%)
ABT Stock Quote Delayed 30 Minutes
Abbott Laboratories Earnings: ABT Stock Surges on Guidance, Q2 Beat
Abbott Laboratories earnings for the company's second quarter of 2019 has ABT stock heading higher Wednesday on positive results.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
187.11B
PE Ratio
32.78
EPS
3.26
Volume (Avg. Vol.)
Day's Range
-
52-Week Range
$89.67 - $121.64
Dividend & Yield
$2.04 (1.91%)
ABT Stock Predictions, Articles, and Abbott Laboratories News
Abbott Labs (ABT) Stock Slips Despite Solid Q4 Earnings
Abbott Labs (ABT) stock was down more than 2% on Wednesday despite the fact that the company's fourth-quarter earnings reached expectations.
5 Must-See Stock Charts for Thursday: ABT, IBM, SBUX, PZZA
IBM, Abbott Labs, Papa John's, Starbucks and Disney round out our must-see stock charts for Thursday. Here's why.
All Signals Are Positive for Buying Abbott Laboratories
Abbott is about to report another quarter to cap 2018's strong annual performance. ABT stock also offers a dividend for income investors.
3 Big Stock Charts for Friday: Incyte, Schlumberger and Abbott Laboratories
The stock charts of INCY, ABT and SLB are set to end the week on a more definitive, trade-worthy footing than most other names.
5 Top Stock Trades for Thursday
A buyout for Ceasars? Earnings from Netflix, Abbott and Lam Research -- we've got it all covered in our top stock trades article.
ABT Stock Dips Following Q3 Earnings Results
ABT stock was down on Wednesday after the healthcare company released its earnings report for the third quarter of the year.
Abbott Laboratories Stock Gets a Boost From Q2 Earnings Beat
Abbott Laboratories (ABT) stock was up on Wednesday following the release of its earnings report for the second quarter of 2018.
3 Big Stock Charts for Wednesday: United Technologies, Abbott Laboratories and Leggett & Platt
Stock charts of United Technologies, Abbott Laboratories and Leggett & Platt have earned a closer look as bullish trading prospects this morning.
Abbott Laboratories Stock Slips Despite Earnings Beat
Abbott Laboratories (ABT) stock as down on Wednesday despite the health care company reporting an earnings beat for the first quarter of 2018.
At $ 59.460, Abbott Laboratories (ABT) a Buy
The Buy for Abbott Laboratories (ABT) this week is based on the latest relative pricing of its shares and market intelligence.
Abbott Laboratories (ABT) a Buy This Week
The Buy for Abbott Laboratories (ABT) this week is based on the latest relative pricing of its shares and news.
Abbott Laboratories (ABT) a Buy at recent price of $63.22, on Robust Earnings Momentum
Portfolio Grader currently ranks ABT as a Buy. This analytical tool evaluates stocks by employing proprietary fundamental and quantitative analytical. This represents no change from the previous week and is the same ranking ABT has had from Portfolio Grader for 4 months.
